Corcept Therapeutics Incorporated
USD87.89
+0.57 (+0.65%)
CEO
Joseph K. Belanoff
IPO Date
2004-04-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$87.42
Prev. Close
$87.32
Day Low
$87.18
Day High
$87.95
52W Low
$28.66
52W High
$91.00
Market Cap
$9.44B
Volume
0.82M
| 5,823 |
| $83.57 |
| 18 Jun 2026 | MAHONEY DAVID L | director | S-Sale | Disposed | 20,000 | $84.53 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | M-Exempt | Acquired | 40,000 | $19.26 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | S-Sale | Disposed | 9,434 | $80.02 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | S-Sale | Disposed | 11,081 | $80.94 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | S-Sale | Disposed | 19,483 | $81.81 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | S-Sale | Disposed | 2 | $82.45 |
| 17 Jun 2026 | Mokari Atabak | Chief Financial Officer | M-Exempt | Disposed | 40,000 | $19.26 |
| 4 Jun 2026 | Guyer William | Chief Development Officer | M-Exempt | Acquired | 20,000 | $21.65 |